Citation: Cj. Calleman, THE METABOLISM AND PHARMACOKINETICS OF ACRYLAMIDE - IMPLICATIONS FOR MECHANISMS OF TOXICITY AND HUMAN RISK-ESTIMATION, Drug metabolism reviews, 28(4), 1996, pp. 527-590
Citation: Lg. Costa et al., EVALUATION OF THE NEUROTOXICITY OF GLYCIDAMIDE, AN EPOXIDE METABOLITEOF ACRYLAMIDE - BEHAVIORAL, NEUROCHEMICAL AND MORPHOLOGICAL-STUDIES, Toxicology, 98(1-3), 1995, pp. 151-161
Authors:
SEGERBACK D
CALLEMAN CJ
SCHROEDER JL
COSTA LG
FAUSTMAN EM
Citation: D. Segerback et al., FORMATION OF N-7-(2-CARBAMOYL-2-HYDROXYETHYL)GUANINE IN DNA OF THE MOUSE AND THE RAT FOLLOWING INTRAPERITONEAL ADMINISTRATION OF [C-14] ACRYLAMIDE, Carcinogenesis, 16(5), 1995, pp. 1161-1165
Authors:
CALLEMAN CJ
WU Y
HE F
TIAN G
BERGMARK E
ZHANG S
DENG H
WANG Y
CROFTON KM
FENNELL T
COSTA LG
Citation: Cj. Calleman et al., RELATIONSHIPS BETWEEN BIOMARKERS OF EXPOSURE AND NEUROLOGICAL EFFECTSIN A GROUP OF WORKERS EXPOSED TO ACRYLAMIDE, Toxicology and applied pharmacology, 126(2), 1994, pp. 361-371
Authors:
DENG H
HE FS
ZHANG SL
CALLEMAN CJ
COSTA LG
Citation: H. Deng et al., QUANTITATIVE MEASUREMENTS OF VIBRATION THRESHOLD IN HEALTHY-ADULTS AND ACRYLAMIDE WORKERS, International archives of occupational and environmental health, 65(1), 1993, pp. 53-56
Citation: Cj. Calleman et al., A NONLINEAR DOSIMETRIC MODEL FOR HEMOGLOBIN ADDUCT FORMATION BY THE NEUROTOXIC AGENT ACRYLAMIDE AND ITS GENOTOXIC METABOLITE GLYCIDAMIDE, Environmental health perspectives, 99, 1993, pp. 221-223
Citation: E. Bergmark et al., DETERMINATION OF HEMOGLOBIN ADDUCTS IN HUMANS OCCUPATIONALLY EXPOSED TO ACRYLAMIDE, Toxicology and applied pharmacology, 120(1), 1993, pp. 45-54